Analyst Reco. RegenETP, Inc.

Equities

Market Closed - OTC Markets Other stock markets 09:30:00 2024-04-17 am EDT			5-day change	1st Jan Change
0.0203 ^USD	0.00%		0.00%	-59.64%

Mar. 22	North American Morning Briefing : Stocks Struggle After New Records	DJ
Feb. 26	PolarityTE Screens First Subject in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers	CI

Northland Securities Adjusts Price Target on PolarityTE to $1 From $1.25, Maintains Outperform Rating	22-12-28	MT
Cantor Fitzgerald Downgrades PolarityTE to Neutral From Overweight, Adjusts Price Target to $1 From $2.50	22-03-31	MT

No results for this search